CFN
TRAW icon

Cordasco Financial Network’s Traws Pharma TRAW Stock Holding History

Cordasco Financial Network’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Buy
+5
New +$169 ﹤0.01% 609

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cordasco Financial Network's TRAW Position: Q2 2022 in Review

Cordasco Financial Network opened a new position in Traws Pharma (TRAW) in Q2 2022: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #609 among its holdings.

30 funds tracked by Wall St. Rank hold TRAW as of Q2 2022.

  • Cordasco Financial Network held 5 shares of Traws Pharma worth $0 as of Q2 2022.
  • Traws Pharma was a new Cordasco Financial Network position in Q2 2022.
  • Traws Pharma made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #609 holding.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.